Baohuoside I suppresses invasion of cervical and breast cancer cells through the downregulation of CXCR4 chemokine receptor expression

Biochemistry

Volumn 53, Issue 48, 2014, Pages 7562-7569

  Kim, Buyun ^a   Park, Byoungduck ^a  

^a Keimyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; PATHOLOGY; TUMORS;

BREAST CANCER CELLS; CANCER METASTASIS; CERVICAL CANCERS; CHEMOKINE LIGANDS; CHEMOKINE RECEPTOR EXPRESSION; CXC CHEMOKINE RECEPTOR 4; MOLECULAR MECHANISM; PROTEIN COUPLED RECEPTORS;

DISEASES;

ANTINEOPLASTIC AGENT; BAOHUOSIDE I; CHEMOKINE RECEPTOR CXCR4; CHLOROQUINE; LACTACYSTIN; MESSENGER RNA; UNCLASSIFIED DRUG; CXCR4 PROTEIN, HUMAN; FLAVONOID; RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BERBERIDACEAE; BREAST CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EPIMEDIUM KOREANUM; FEMALE; HELA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; METASTASIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UTERINE CERVIX CANCER; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; DOSE RESPONSE; DRUG EFFECTS; EPIMEDIUM; GENETICS; METABOLISM; NEOPLASM INVASIVENESS; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVICAL NEOPLASMS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EPIMEDIUM; FEMALE; FLAVONOIDS; HELA CELLS; HEP G2 CELLS; HUMANS; NEOPLASM INVASIVENESS; RECEPTORS, CXCR4; RNA, MESSENGER; RNA, NEOPLASM; UTERINE CERVICAL NEOPLASMS;

EID: 84916223205     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi5011927     Document Type: Article

References (50)

1. Forouzanfar, M. H., Foreman, K. J., Delossantos, A. M., Lozano, R., Lopez, A. D., Murray, C. J., and Naghavi, M. (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: A systematic analysis. Lancet 378, 1461-1484.
2. Guarneri, V., and Conte, P. (2009) Metastatic breast cancer: Therapeutic options according to molecular subtypes and prior adjuvant therapy. Oncologist 14, 645-656.
3. Kim, H. S., Lee, S. Y., Oh, S. C., Choi, C. W., Kim, J. S., and Seo, J. H. (2014) Case Report of Pulmonary Sarcoidosis Suspected to be Pulmonary Metastasis in a Patient with Breast Cancer. Cancer Research and Treatment 46, 317-321.
4. Yamamoto, K., Yoshikawa, H., Shiromizu, K., Saito, T., Kuzuya, K., Tsunematsu, R., and Kamura, T. (2004) Pulmonary metastasectomy for uterine cervical cancer: A multivariate analysis. The Annals of Thoracic Surgery 77, 1179-1182.
5. Mishima, M., Toh, U., Iwakuma, N., Takenaka, M., Furukawa, M., and Akagi, Y. (2014) Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer. Breast Cancer, DOI: 10.1007/s12282-014-0560-0.
6. Thanapprapasr, D., Nartthanarung, A., Likittanasombut, P., Na Ayudhya, N. I., Charakorn, C., Udomsubpayakul, U., Subhadarbandhu, T., and Wilailak, S. (2010) Bone metastasis in cervical cancer patients over a 10-year period. International Journal of Gynecological Cancer 20, 373-378.
7. Rucci, N., Sanita, P., Delle Monache, S., Alesse, E., and Angelucci, A. (2014) Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. World Journal of Clinical Oncology 5, 335-347.
8. Chambers, A. F., Groom, A. C., and MacDonald, I. C. (2002) Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2, 563-572.
9. Raman, D., Baugher, P. J., Thu, Y. M., and Richmond, A. (2007) Role of chemokines in tumor growth. Cancer Lett. 256, 137-165.
10. Hembruff, S. L., and Cheng, N. (2009) Chemokine signaling in cancer: Implications on the tumor microenvironment and therapeutic targeting. Cancer Ther. 7, 254-267.
11. Charo, I. F., and Ransohoff, R. M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621.
12. Schwartz, V., Lue, H., Kraemer, S., Korbiel, J., Krohn, R., Ohl, K., Bucala, R., Weber, C., and Bernhagen, J. (2009) A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 583, 2749-2757.
13. Balkwill, F. (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin. Cancer Biol. 14, 171-179.
14. Zhang, J. P., Lu, W. G., Ye, F., Chen, H. Z., Zhou, C. Y., and Xie, X. (2007) Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma. International Journal of Gynecological Cancer 17, 478-483.
15. Liang, Z., Yoon, Y., Votaw, J., Goodman, M. M., Williams, L., and Shim, H. (2005) Silencing of CXCR4 blocks breast cancer metastasis. Cancer Res. 65, 967-971.
16. Scotton, C. J., Wilson, J. L., Milliken, D., Stamp, G., and Balkwill, F. R. (2001) Epithelial cancer cell migration: A role for chemokine receptors? Cancer Res. 61, 4961-4965.
17. Mukherjee, D., and Zhao, J. (2013) The role of chemokine receptor CXCR4 in breast cancer metastasis. Am. J. Cancer Res. 3, 46-57.
18. Scotton, C. J., Wilson, J. L., Scott, K., Stamp, G., Wilbanks, G. D., Fricker, S., Bridger, G., and Balkwill, F. R. (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 62 , 5930-5938.
19. Newman, D. J. (2008) Natural products as leads to potential drugs: An old process or the new hope for drug discovery? J. Med. Chem. 51, 2589-2599.
20. Dou, J., Liu, Z., and Liu, S. (2006) Structure identification of a prenylflavonol glycoside from Epimedium koreanum by electrospray ionization tandem mass spectrometry. Anal. Sci. 22, 449-452.
21. Meng, F. H., Li, Y. B., Xiong, Z. L., Jiang, Z. M., and Li, F. M. (2005) Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 12, 189-193.
22. Lee, K. S., Lee, H. J., Ahn, K. S., Kim, S. H., Nam, D., Kim, D. K., Choi, D. Y., and Lu, J. (2009) Cyclooxygenase-2/prostaglandin E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells. Cancer Lett. 280, 93-100.
23. Kim, S. H., Ahn, K. S., Jeong, S. J., Kwon, T. R., Jung, J. H., Yun, S. M., Han, I., Lee, S. G., Kim, D. K., Kang, M., Chen, C. Y., and Lee, J. W. (2011) Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Eur. J. Pharmacol. 654, 10-16.
24. Choi, H. J., Eun, J. S., Kim, D. K., Li, R. H., Shin, T. Y., Park, H., Cho, N. P., and Soh, Y. (2008) Icariside II from Epimedium koreanum inhibits hypoxia-inducible factor-1α in human osteosarcoma cells. Eur. J. Pharmacol. 579, 58-65.
25. Wu, J., Zuo, F., Du, J., Wong, P. F., Qin, H., and Xu, J. (2013) Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells. Mol. Med. Rep. 8, 597-602.
26. Huang, C., Chen, X., Guo, B., Huang, W., Shen, T., Sun, X., Xiao, P., and Zhou, Q. (2012) Induction of apoptosis by Icariside II through extrinsic and intrinsic signaling pathways in human breast cancer MCF7 cells. Biosci., Biotechnol., Biochem. 76, 1322-1328.
27. Chung, B. H., Kim, J. D., Kim, C. K., Kim, J. H., Won, M. H., Lee, H. S., Dong, M. S., Ha, K. S., Kwon, Y. G., and Kim, Y. M. (2008) Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. Biochem. Biophys. Res. Commun. 376 , 404-408.
28. Choi, H. J., Park, Y. R., Nepal, M., Choi, B. Y., Cho, N. P., Choi, S. H., Heo, S. R., Kim, H. S., Yang, M. S., and Soh, Y. (2010) Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-κB signaling pathways. Eur. J. Pharmacol. 636, 28-35.
29. Yadav, S. S., Prasad, S. B., Das, M., Kumari, S., Pandey, L. K., Singh, S., Pradhan, S., and Narayan, G. (2014) Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer. BioMed Res. Int. 2014, 581403.
30. Huang, Y., Zhang, J., Cui, Z. M., Zhao, J., and Zheng, Y. (2013) Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer. Chin. J. Cancer 32, 289-296.
31. Fernandis, A. Z., Cherla, R. P., Chernock, R. D., and Ganju, R. K. (2002) CXCR4/CCR5 down-modulation and chemotaxis are regulated by the proteasome pathway. J. Biol. Chem. 277, 18111-18117.
32. Bhandari, D., Trejo, J., Benovic, J. L., and Marchese, A. (2007) Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J. Biol. Chem. 282, 36971-36979.
33. Penzo, M., Habiel, D. M., Ramadass, M., Kew, R. R., and Marcu, K. B. (2014) Cell migration to CXCL12 requires simultaneous IKKα and IKKβ-dependent NF-κ signaling. Biochim. Biophys. Acta 1843, 1796-1804.
34. Shen, X. Y., Wang, S. H., Liang, M. L., Wang, H. B., Xiao, L., and Wang, Z. H. (2008) [The role and mechanism of CXCR4 and its ligand SDF-1 in the development of cervical cancer metastasis]. Ai Zheng 27, 1044-1049.
35. Wei, M., Liang, L. Z., Zhang, C. Q., Xiong, Y., Zhang, Y., Shen, Y., and Li, J. Q. (2007) [Correlation of CXCR4/CXCL12 overexpression to lymph node metastasis and chronic inflammation in cervical adenocarcinoma]. Ai Zheng 26, 298-302.
36. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50-56.
37. Su, Y. C., Wu, M. T., Huang, C. J., Hou, M. F., Yang, S. F., and Chai, C. Y. (2006) Expression of CXCR4 is associated with axillary lymph node status in patients with early breast cancer. Breast 15, 533-539.
38. Tanaka, T., Bai, Z., Srinoulprasert, Y., Yang, B. G., Hayasaka, H., and Miyasaka, M. (2005) Chemokines in tumor progression and metastasis. Cancer Sci. 96, 317-322.
39. Roy, I., Zimmerman, N. P., Mackinnon, A. C., Tsai, S., Evans, D. B., and Dwinell, M. B. (2014) CXCL12 chemokine expression suppresses human pancreatic cancer growth and metastasis. PLoS One 9 , e90400.
40. Li, Y., Shen, Y., Miao, Y., Luan, Y., Sun, B., and Qiu, X. (2014) Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer. Int. J. Clin. Exp. Pathol. 7, 3771-3780.
41. Proudfoot, A. E. (2002) Chemokine receptors: Multifaceted therapeutic targets. Nat. Rev. Immunol. 2, 106-115.
42. Marchese, A., and Benovic, J. L. (2001) Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol. Chem. 276, 45509-45512.
43. Liu, Y. L., Yu, J. M., Song, X. R., Wang, X. W., Xing, L. G., and Gao, B. B. (2006) Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines. Cancer Biol. Ther. 5, 1320-1326.
44. Helbig, G., Christopherson, K. W., II, Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., and Nakshatri, H. (2003) NF-κ promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278, 21631-21638.
45. Bachelder, R. E., Wendt, M. A., and Mercurio, A. M. (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 62, 7203-7206.
46. Burger, J. A., and Kipps, T. J. (2006) CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107, 1761-1767.
47. Sethi, G., and Tergaonkar, V. (2009) Potential pharmacological control of the NF-κ pathway. Trends Pharmacol. Sci. 30, 313-321.
48. Wang, L., Lu, A., Liu, X., Sang, M., Shan, B., Meng, F., Cao, Q., and Ji, X. (2011) The flavonoid Baohuoside-I inhibits cell growth and downregulates survivin and cyclin D1 expression in esophageal carcinoma via β-catenin-dependent signaling. Oncol. Rep. 26, 1149-1156.
49. Song, J., Shu, L., Zhang, Z., Tan, X., Sun, E., Jin, X., Chen, Y., and Jia, X. (2012) Reactive oxygen species-mediated mitochondrial pathway is involved in Baohuoside I-induced apoptosis in human non-small cell lung cancer. Chem.-Biol. Interact. 199, 9-17.
50. Wang, T., Zhang, J. C., Chen, Y., Huang, F., Yang, M. S., and Xiao, P. G. (2007) [Comparison of antioxidative and antitumor activities of six flavonoids from Epimedium koreanum]. Zhongguo Zhong Yao Za Zhi 32, 715-718.